|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows Used In Operating Activities: | |||||
| Net loss | |||||
| Reconciliation of net loss to cash used in operating activities: | |||||
| Depreciation | |||||
| (Gain) loss on the sale of equipment | |||||
| Accretion of asset retirement obligations | |||||
| Stock-based compensation | |||||
| Change in marketable securities | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Reclamation liability | |||||
| Deferred revenue | |||||
| Asset retirement obligations | |||||
| Contingent consideration | |||||
| Net cash used in operating activities | |||||
| Cash Flows Used In Investing Activities | |||||
| Purchase of property, plant & equipment and mineral properties | |||||
| Proceeds from sale of equipment | |||||
| Net cash used in investing activities | |||||
| Cash Flows Provided By Financing Activities | |||||
| Proceeds from warrant exercises | |||||
| Cash received from note receivable | |||||
| Net cash provided by financing activities | |||||
| Effect of foreign exchange rate on cash | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash - beginning | |||||
| Cash and cash equivalents and restricted cash - ending | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest | |||||
| Notes received in exchange for equipment sold | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current portion | |||||
| Restricted cash, noncurrent | |||||
Loading...